Yirui Shi
321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Allogeneic mesenchymal stromal cells ameliorate lupus nephritis by regulating lipid metabolism via ASGR1.
Journal: Stem cell research & therapy
Published: January 04, 2026
Allogeneic umbilical cord-derived mesenchymal stromal cells for treatment of refractory lupus nephritis: a real-world study.
Journal: Stem cell research & therapy
Published: November 16, 2025
3D-Mesenchymal stromal cells derived VASH2 alleviates oxidative stress-induced endothelial senescence by mediating α-tubulin detyrosination in systemic sclerosis.
Journal: Journal of translational medicine
Published: October 23, 2025
Comparison of telitacicept and belimumab in systemic lupus erythematosus: a real-word retrospective study.
Journal: Clinical rheumatology
Published: April 28, 2025
Engineered MSC Aggregates with E/N-Cadherin and IL-6 Preconditioning for the Treatment of Systemic Sclerosis.
Journal: Advanced healthcare materials
Published: February 06, 2025
Mesenchymal stem cells improve ovarian function by suppressing fibrosis through CTGF/FAK signalling in systemic lupus erythematosus.
Journal: Lupus science & medicine
Published: November 29, 2024
The effect of tocilizumab treatment for skin fibrosis by inhibiting CD38+ macrophages in systemic sclerosis.
Journal: Cellular immunology
Published: November 14, 2024
Improvement in long-term survival with mesenchymal stem cell transplantation in systemic sclerosis patients: a propensity score-matched cohort study.
Journal: Stem cell research & therapy
Published: October 15, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026